These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1984463)

  • 1. Pharmacokinetics of intravenous pentamidine in patients with normal renal function or receiving hemodialysis.
    Conte JE
    J Infect Dis; 1991 Jan; 163(1):169-75. PubMed ID: 1984463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentamidine pharmacokinetics in patients with AIDS with impaired renal function.
    Conte JE; Upton RA; Lin ET
    J Infect Dis; 1987 Dec; 156(6):885-90. PubMed ID: 3680992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma pentamidine concentrations vary between individuals with Pneumocystis carinii pneumonia and the drug is actively secreted by the kidney.
    Lidman C; Bronner U; Gustafsson LL; Rombo L
    J Antimicrob Chemother; 1994 Apr; 33(4):803-10. PubMed ID: 8056699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations of aerosolized pentamidine in bronchoalveolar lavage, systemic absorption, and excretion.
    Conte JE; Golden JA
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1490-3. PubMed ID: 3263832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a specific and sensitive assay to determine pentamidine pharmacokinetics in patients with AIDS.
    Conte JE; Upton RA; Phelps RT; Wofsy CB; Zurlinden E; Lin ET
    J Infect Dis; 1986 Dec; 154(6):923-9. PubMed ID: 3491164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacologic studies with pentamidine aerosol in HIV patients].
    Vöhringer HF; Arasteh K; Hardtmann E; Hornscheidt M
    Med Klin (Munich); 1990 Apr; 85 Suppl 2():248-50, 291. PubMed ID: 2374528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of cefepime in subjects with renal insufficiency.
    Barbhaiya RH; Knupp CA; Forgue ST; Matzke GR; Guay DR; Pittman KA
    Clin Pharmacol Ther; 1990 Sep; 48(3):268-76. PubMed ID: 2401125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.
    Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT
    Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentamidine therapy in renal failure: case report and literature review.
    Fitzsimmons WE; Luskin SS
    Drug Intell Clin Pharm; 1988 Jan; 22(1):25-8. PubMed ID: 3280279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of ceftazidime in patients with renal insufficiency and in those undergoing hemodialysis.
    Ohkawa M; Nakashima T; Shoda R; Ikeda A; Orito M; Sawaki M; Sugata T; Shimamura M; Hirano S; Okumura K
    Chemotherapy; 1985; 31(6):410-6. PubMed ID: 3908006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of rilmenidine in patients with chronic renal insufficiency and in hemodialysis patients.
    Aparicio M; Dratwa M; el Esper N; Fillastre JP; Levaltier B; Lins R; Meyrier A; Mignon F; Ryckelynck JP; Sennesael J
    Am J Cardiol; 1994 Dec; 74(13):43A-50A. PubMed ID: 7998585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and adverse reactions after a single dose of pentamidine in patients with Trypanosoma gambiense sleeping sickness.
    Bronner U; Gustafsson LL; Doua F; Ericsson O; Miézan T; Rais M; Rombo L
    Br J Clin Pharmacol; 1995 Mar; 39(3):289-95. PubMed ID: 7619671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of meropenem in patients with various degrees of renal function, including patients with end-stage renal disease.
    Chimata M; Nagase M; Suzuki Y; Shimomura M; Kakuta S
    Antimicrob Agents Chemother; 1993 Feb; 37(2):229-33. PubMed ID: 8452352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of amantadine hydrochloride in subjects with normal and impaired renal function.
    Horadam VW; Sharp JG; Smilack JD; McAnalley BH; Garriott JC; Stephens MK; Prati RC; Brater DC
    Ann Intern Med; 1981 Apr; 94(4 pt 1):454-8. PubMed ID: 7212501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of azlocillin in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Godin M; Fillastre JP
    Antimicrob Agents Chemother; 1980 Mar; 17(3):344-9. PubMed ID: 7425600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of cefprozil in healthy subjects and patients with renal impairment.
    Shyu WC; Pittman KA; Wilber RB; Matzke GR; Barbhaiya RH
    J Clin Pharmacol; 1991 Apr; 31(4):362-71. PubMed ID: 2037710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal.
    Erikson LO; Wåhlin-Boll E; Odar-Cederlöf I; Lindholm L; Melander A
    Eur J Clin Pharmacol; 1989; 36(2):165-74. PubMed ID: 2721541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of cefodizime in volunteers with normal or impaired renal function.
    Conte JE
    J Clin Pharmacol; 1994 Nov; 34(11):1066-70. PubMed ID: 7876397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0 g) coadministered to subjects with normal renal function, patients with decreased renal function, and patients with end-stage renal disease on hemodialysis.
    Reitberg DP; Marble DA; Schultz RW; Whall TJ; Schentag JJ
    Antimicrob Agents Chemother; 1988 Apr; 32(4):503-9. PubMed ID: 3377461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.